Presentations Image EN Corporate / 31.08.2022 IBA Half Year Results 2022 Press release and presentation Read more IBA Half Year Results 2022 Press release and presentation
Press releases Image EN FR Corporate / 31.08.2022 IBA Reports Half Year 2022 Results Read more IBA Reports Half Year 2022 Results
Press releases Image EN FR Dosimetry / 30.08.2022 IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy Read more IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy
Press releases Image EN FR RadioPharma Solutions / 30.08.2022 CNRT and IBA sign collaboration agreement to install a Cyclone® IKON in China Read more CNRT and IBA sign collaboration agreement to install a Cyclone® IKON in China
Press releases Image EN FR Proton Therapy / 26.08.2022 IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain Read more IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain
Press releases Image EN FR Proton Therapy / 18.08.2022 IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia Read more IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia
Press releases Image EN FR Proton Therapy / 02.08.2022 IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy Read more IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
Press releases Image EN FR Corporate / 11.07.2022 IBA Notice of Half Year 2022 Results and Conference Call Read more IBA Notice of Half Year 2022 Results and Conference Call
Press releases Image FR EN Proton Therapy / 30.06.2022 IBA launches the ConformalFLASH® Alliance Read more IBA launches the ConformalFLASH® Alliance
Press releases Image EN FR Proton Therapy / 30.06.2022 IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy Read more IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy
Press releases Image EN FR Proton Therapy / 01.06.2022 IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA Read more IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA
Legal Image EN FR CN DE PT IT RU ES Corporate / 31.05.2022 IBA Website Personal Data Policy Read more IBA Website Personal Data Policy
Brochures Image EN FR Corporate / 23.05.2022 IBA Corporate Brochure 2022 Read more IBA Corporate Brochure 2022
Press releases Image EN FR Corporate / 19.05.2022 IBA Business Update – First Quarter 2022 Read more IBA Business Update – First Quarter 2022
Press releases Image EN FR Dosimetry / 07.05.2022 IBA continues to shape the future of dosimetry at ESTRO 2022 Read more IBA continues to shape the future of dosimetry at ESTRO 2022
Press releases Image EN FR Proton Therapy / 06.05.2022 IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress Read more IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress
Press releases Image EN FR Proton Therapy / 05.05.2022 IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China Read more IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China
Press releases Image EN FR Dosimetry / 03.05.2022 IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc. Read more IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.
